Shutting Down the ‘Language Encoder’: A Pathogen‐Derived Nano‐Interferer Disrupt Sialylation Metabolism and Reprogram Intercellular Communication in Glioblastoma
Advanced Materials · 2026
DOI: 10.1002/adma.202516608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Jingyi Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, State…. Hauptthemen laut MEDLINE: Glioblastoma, Cell Communication, N-Acetylneuraminic Acid, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shanghai Major Science and Technology Special Project.
Abstract (Originalsprache)
Glioblastoma (GBM), constrained by the limited cranial space and the blood–brain barrier (BBB), establishes a rapidly adaptable, generalized communication network through enhanced terminal sialylation of membrane proteins. This metabolism‐driven network encodes cellular metabolic states into functional information at the membrane level, thereby markedly enhancing signaling plasticity, intercellular communication, and immune evasion, which together sustain and expand malignant phenotypes within a resource‐limited microenvironment. Here, a “metabolism‐guided decoding of communication architecture” strategy is proposed and developed a brain‐targeted pathogen‐derived nano‐interferer (OMV@HM‐T/F). By simultaneously inhibiting glycosylation precursor synthesis and sialic acid activation, the platform remodels membrane glycan structures, disrupts glycan‐dependent communication scaffolds, and effectively blocks downstream signal amplification and immune suppression pathways. Integrating BBB penetrability with tumor microenvironment responsiveness, this strategy enables precise metabolic‐level intervention, offering a promising approach to overcoming high adaptability and therapeutic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center…
ORCID-Profile: Tao Sun, Chen Jiang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shanghai Major Science and Technology Special Project
- Open Research Fund of Pingyuan Laboratory
- Ethics Committee of Shanghai General Hospital
- National Key Research and Development Program of China
Zitieren
APA
Zhou, J., Tian, Z., Chen, Y., Zhao, Z., Li, X., Song, H., Fan, H., Wu, Y., Wu, D., Geng, S., Liu, Y., Sun, T., & Jiang, C. (2026). Shutting Down the ‘Language Encoder’: A Pathogen‐Derived Nano‐Interferer Disrupt Sialylation Metabolism and Reprogram Intercellular Communication in Glioblastoma. Advanced Materials. https://doi.org/10.1002/adma.202516608
Vancouver
Zhou J, Tian Z, Chen Y, Zhao Z, Li X, Song H, et al. Shutting Down the ‘Language Encoder’: A Pathogen‐Derived Nano‐Interferer Disrupt Sialylation Metabolism and Reprogram Intercellular Communication in Glioblastoma. Advanced Materials. 2026. doi:10.1002/adma.202516608
BibTeX
@article{Zhou2026,
author = {Zhou, Jingyi and Tian, Zonghua and Chen, Yun and Zhao, Zhenhao and Li, Xuwen and Song, Haolin and Fan, Hongrui and Wu, Yuxing and Wu, Dongxu and Geng, Shuo and Liu, Yuchen and Sun, Tao and Jiang, Chen},
title = {Shutting Down the ‘Language Encoder’: A Pathogen‐Derived Nano‐Interferer Disrupt Sialylation Metabolism and Reprogram Intercellular Communication in Glioblastoma},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202516608}
}
EUVIMED